Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Quotient Sciences is a drug development and clinical trial services company offering integrated translational and clinical pharmacology capabilities,including…
- Coverage: Global · Phase I–III
- Therapeutic focus: Oncology, Immunology, Infectious Disease, CNS and 1 more
- Scale: Small,Medium
Company fit
Best suited for
Early-phase and clinical pharmacology trials needing formulation + clinical under one roof
Study fit
Best suited for early-phase and clinical pharmacology trials needing formulation + clinical under one roof.
Core strengths
- Integrated drug development
- Clinical pharmacology expertise
- UK-based with US ops
Considerations
- Focused on early-phase
- Not a traditional full-service CRO for Phase III
Key facts
- Category
- Clinical CRO
- Geography
- Global
- Studies managed
- 200
- HQ
- United Kingdom
- Company size
- 100 employees
- Year founded
- 2015
Publications
Reviewed vendor articles, separate from independent ratings.
Browse the publications library